Roivant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference

Wednesday, January 8, 2020 Press Release
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK and BASEL, Switzerland, Jan. 8, 2020 /PRNewswire/ -- Roivant Sciences today announced that Vivek Ramaswamy, Founder and Chief Executive Officer of Roivant, will present an overview of recent developments and future directions for the business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

The company's presentation is scheduled to begin at 10:30 a.m. PT on Tuesday, January 14, 2019 at the Westin St. Francis.

Roivant recently announced the close of its transaction forming a strategic alliance with Sumitomo Dainippon Pharma. The company will discuss this transaction and other business updates during its presentation.

About Roivant SciencesRoivant Sciences aims to improve health by rapidly delivering innovative medicines and technologies to patients. Roivant does this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology to drive greater efficiency in R&D and commercialization.

For more information, please visit www.roivant.com.

Media Contact:Paul Davispaul.davis@roivant.com

Cision View original content:http://www.prnewswire.com/news-releases/roivant-sciences-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300983192.html

SOURCE Roivant Sciences



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Diabetes Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store